Cargando…
Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer
It has been reported that circulating tumor cells (CTCs) are beneficial for predicting tumor stage or treatment response. Although epithelial cell adhesion molecules (EpCAMs) and cytokeratin (CK) have been often used for the identification of CTCs, other tumor markers have not been fully investigate...
Autores principales: | Miki, Yuichiro, Yashiro, Masakazu, Kuroda, Kenji, Okuno, Tomohisa, Togano, Shingo, Masuda, Go, Kasashima, Hiroaki, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877362/ https://www.ncbi.nlm.nih.gov/pubmed/33381922 http://dx.doi.org/10.1002/cam4.3616 |
Ejemplares similares
-
Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer
por: Miki, Yuichiro, et al.
Publicado: (2018) -
Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor
por: Kuroda, Kenji, et al.
Publicado: (2020) -
Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
por: Kitayama, Kishu, et al.
Publicado: (2017) -
Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
por: Yashiro, Masakazu, et al.
Publicado: (2021) -
Gastric cancer stem cells survive in stress environments via their autophagy system
por: Togano, Shingo, et al.
Publicado: (2021)